Venktaraman, 2016 [45] |
Fibre |
20 |
Healthy |
19–20 |
3 |
RS2 |
24 |
↑ Ruminococcus bromii, Bifiodbacterium adolescentis
|
↑ Butyrate |
Zhang, 2019 [48] |
Randomized, Double-Blind |
19 |
Healthy |
18–55 |
4 |
RS2 |
40 |
↑ Ruminococcaceae_UCG-005 ↓ Coprococcus, Bacteroides
|
↓ Body Fat (%), LDL ↑ GLP-1, Acetate |
Benítez-Páez, 2019 [50] |
Randomized Crossover |
30 |
Obese |
36–52 |
4 |
Arabinoxylan |
10 |
↑ Prevotella
|
↑ SCFA |
Lu, 2004 [144] |
Randomized Crossover |
15 |
T2D |
30–74 |
5 |
Arabinoxylan |
15 |
Not measured |
↓ Fasting glucose and insulin |
Nicolucci, 2017 [163] |
Double-Blind, Placebo |
22 |
Obese |
7–12 |
16 |
Inulin |
10 |
↑ Bifidobacterium
|
↓ Body Weight, Body Fat (%), TAG |
Ramirez-Faris, 2008 [57] |
Randomized, Crossover |
12 |
Healthy |
30–64 |
3 |
Inulin |
5 |
↑Faecalibacterium prausnitzii
|
Not measured |
Wang, 2016 [66] |
Randomized, Crossover |
30 |
Metabolic Syndrome |
27–78 |
5 |
ß-glucan |
5 |
↑ Bacteroides, Prevotella ↓ Dorea
|
↓ Total Cholesterol |
Mitsou, 2010 [69] |
Randomized, Double-Blind, Placebo |
52 |
Healthy |
39–70 |
4 |
ß-glucan |
1 |
↑ Bfidobacterium, ↓ Bacteroides
|
No significant change |
Lappi, 2013 [85] |
Randomized, Parallel |
52 |
Metabolic Syndrome |
40–65 |
12 |
Rye |
75 |
↑ Collinsella, Clostridium XIV Bacteroides |
No significant change |
Lee, 2016 [184] |
Randomized, Crossover |
|
Healthy |
18–60 |
|
Rye |
40 |
Not measured |
↓ Postprandial Glucose and Insulin |
Vitaglione, 2015 [63] |
Randomized, Parallel, Placebo |
80 |
Obese |
19–67 |
8 |
Wheat |
70 |
↑ Firmicutes, Bacteroidetes ↓ Clostridium
|
No significant change |
Dall’Alba, 2013 [151] |
Randomized, Parallel |
44 |
T2D |
32–75 |
6 |
Gum guar |
10 |
Not measured |
↓ Waist Circumference, HbA1c, TAG |